The partnership aims to create a non-viral system to expedite engineered cell therapy delivery by addressing bottlenecks.

Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Basilard BioTech, a Southern California biotechnology company pioneering novel ...

The medium, which is designed for high density perfusion culture, is available in a variety of media package options for continuous processing.

FUJIFILM Biosciences launches BalanCD HEK293 Perfusion A to boost scalable viral vector production for gene therapy.

LONDON, GREATER LONDON, UNITED KINGDOM, September 10, 2025 /EINPresswire.com/ -- What Is The Expected Cagr For The Cell Therapy Raw Materials Market Through 2025? There has been a significant increase ...

IMUNON (IMNN) announced that new translational data from the Phase 2 OVATION 2 Study of IMNN-001, its investigational therapy for the treatment of ...

Gene therapy offers the possibility of addressing cancer at its molecular roots by targeting disease-causing genes rather than relying solely on surgery, chemotherapy, or radiotherapy.

Impurities and instability are challenges for all drugs, but a growing range of technological tools are helping drug developers and manufacturers minimize them.

These findings further support the development of PulseSight’s lead therapy, PST-611, a first-in-class non-viral vectorized therapy encoding transferrin to restore iron balance and preserve retinal ...